Trials / Completed
CompletedNCT00705510
Efficacy of 0.05 % Cyclosporine Ophthalmic Emulsion Compare With Tear in Meibomian Gland Dysfunction
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 70 (actual)
- Sponsor
- Mahidol University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy of 0.05% cyclosporine ophthalmic emulsion (Restasis® , Allergan) versus an artificial tears alone in patients with meibomian gland dysfunction that have abnormal tear quality and quantity by subjective symptoms and signs including tear breakup time
Detailed description
Meibomian gland dysfunction patients will divide into 2 groups. One group will have 0.05% cyclosporine opthalmic emulsion and the other will have non-preservative artificial tear twice daily, compare the result in 3 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 0.05% cyclosporin eye drop | use the medication twice daily for 3 months |
Timeline
- Start date
- 2008-05-01
- Primary completion
- 2010-10-01
- Completion
- 2010-10-01
- First posted
- 2008-06-26
- Last updated
- 2010-11-09
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT00705510. Inclusion in this directory is not an endorsement.